Testing effectiveness (Phase 2)Study completedNCT00017862
What this trial is testing
Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
Who this might be right for
Hypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 10